Endexx Corporation EDXC reported its quarterly earnings on Tuesday for the quarter ending March 31, 2023, revealing over $2.8 million in revenue compared to $254,686 in the same quarter of last year, representing a whopping 1013% year-over-year increase.
Todd Davis, the company's chairman and CEO, touted the quarterly results.
"Consolidating the audited financials and integrating Hyla's operations into Endexx, we've catapulted into an era marked by unprecedented growth, painting Fiscal 2023 as a canvas of resurgence and robust expansion amidst a two-year stagnation in the cannabis and hemp industry," Davis said.
See Also: Endexx FY22 Revenue Grows 229% YoY, Here Is What You Need To Know
Quarterly Financial Highlights
- Gross profit totaled $394,191 compared to $ 175,730 in the prior year.
- Total operating expenses amounted to $811,200, up from $751,677 in the same quarter of fiscal 2022.
- Loss from operations was $417,009, down from $575,947 in the same period of last year.
- Net loss was $1.52 million, down from $2.8 million in the corresponding quarter of 2022.
- As of March 31, the company had $155,013 in cash, down from $656,776 as of September 30, and $12.7 million in total assets, down from $13.8 million as of September 30.
What's Next
The management's plans include the "sustained and aggressive marketing of hemp cannabidiol products and raising additional capital through sales of equity or debt securities as may be necessary to pursue its business plans and sustain operations until such time as the company can achieve profitability," the company said in filing with the U.S. Securities and Exchange Commission (SEC).
The company develops hemp-derived, cannabidiol-based products through its CBD Unlimited subsidiary.
To learn more about cannabis companies and their financial performance, come join us at the upcoming Benzinga cannabis event in Chicago.
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo: Courtesy of Hvoenok and GOR Photo on Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.